Immunoblotting revealed a notable reduction of H3K9ac level only in the Cpd_DC60 treated leukemia cells (Fig. 5F), marking Cpd_DC60 as our leading SGF29 inhibitor. This evidence concerns the gene SGF29 and leukemia.